Altering the specificity of NK:target cell interactions by genetic manipulation of NK receptor expression on primary mouse NK cells

Vaccine

Volumn 28, Issue 22, 2010, Pages 3767-3772

  Tran, Jimmy ^a   Mahmood, Sajid ^a   Carlyle, James R ^b   Kung, Sam K P ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Sunnybrook Health Sciences Centre   (Canada)

Author keywords

Lentiviral vectors; NK and immunotherapy

Indexed keywords

C TYPE LECTIN RELATED FAMILY MEMBER B; LECTIN; LENTIVIRUS VECTOR; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR P1B; OSTEOCLAST INHIBITORY LECTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL INTERACTION; CELL MANIPULATION; CELL SPECIFICITY; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC ENGINEERING; GENETIC MANIPULATION; GENETIC TRANSDUCTION; IMMUNOTHERAPY; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TARGET CELL;

ANIMALS; CELL DEGRANULATION; CELL LINE; FLOW CYTOMETRY; GENETIC VECTORS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LENTIVIRUS; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC;

EID: 77952546385     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.03.013     Document Type: Article

References (24)

1. Lanier L.L. NK cell receptors. Annu Rev Immunol 16 (1998) 359-393
2. Moretta L., Bottino C., Cantoni C., Mingari M.C., and Moretta A. Human natural killer cell function and receptors. Curr Opin Pharmacol 1 4 (2001) 387-391
3. Yokoyama W.M., and Plougastel B.F. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 3 4 (2003) 304-316
4. Binstadt B.A., Brumbaugh K.M., and Leibson P.J. Signal transduction by human NK cell MHC-recognizing receptors. Immunol Rev 155 (1997) 197-203
5. Long E.O. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 17 (1999) 875-904
6. Orange J.S., Fassett M.S., Koopman L.A., Boyson J.E., and Strominger J.L. Viral evasion of natural killer cells. Nat Immunol 3 11 (2002) 1006-1012
7. Tran J., and Kung S.K. Lentiviral vectors mediate stable and efficient gene delivery into primary murine natural killer cells. Mol Ther 15 7 (2007) 1331-1339
8. Carlyle J.R., Martin A., Mehra A., Attisano L., Tsui F.W., and Zuniga-Pflucker J.C. Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function. J Immunol 162 10 (1999) 5917-5923
9. Kung S.K., Su R.C., Shannon J., and Miller R.G. The NKR-P1B gene product is an inhibitory receptor on SJL/J NK cells. J Immunol 162 10 (1999) 5876-5887
10. Carlyle J.R., Jamieson A.M., Gasser S., Clingan C.S., Arase H., and Raulet D.H. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc Natl Acad Sci USA 101 10 (2004) 3527-3532
11. Sanderson S., and Shastri N. LacZ inducible, antigen/MHC-specific T cell hybrids. Int Immunol 6 3 (1994) 369-376
12. Kung S.K., An D.S., and Chen I.S. A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes. J Virol 74 8 (2000) 3668-3681
13. Vahlne G., Becker S., Brodin P., and Johansson M.H. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells. Scand J Immunol 67 1 (2008) 1-11
14. Carlyle J.R., Mesci A., Ljutic B., Belanger S., Tai L.H., Rousselle E., et al. Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells. J Immunol 176 12 (2006) 7511-7524
15. Winchester B.G. Lysosomal membrane proteins. Eur J Paediatr Neurol 5 Suppl. A (2001) 11-19
16. Peters P.J., Borst J., Oorschot V., Fukuda M., Krahenbuhl O., Tschopp J., et al. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 173 5 (1991) 1099-1109
17. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 1-2 (2003) 65-78
18. Alter G., Malenfant J.M., and Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294 1-2 (2004) 15-22
19. Colucci F., Caligiuri M.A., and Di Santo J.P. What does it take to make a natural killer?. Nat Rev Immunol 3 5 (2003) 413-425
20. Chan C.J., Andrews D.M., and Smyth M.J. Can NK cells be a therapeutic target in human cancer?. Eur J Immunol 38 11 (2008) 2964-2968
21. Ruggeri L., Mancusi A., Burchielli E., Aversa F., Martelli M.F., and Velardi A. Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. Curr Opin Oncol 19 2 (2007) 142-147
22. Diefenbach A., Jensen E.R., Jamieson A.M., and Raulet D.H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413 6852 (2001) 165-171
23. Pegram H.J., Jackson J.T., Smyth M.J., Kershaw M.H., and Darcy P.K. Adoptive transfer of gene-modified primary NK cells can specifically inhibit tumor progression in vivo. J Immunol 181 5 (2008) 3449-3455
24. Kruschinski A., Moosmann A., Poschke I., Norell H., Chmielewski M., Seliger B., et al. Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas. Proc Natl Acad Sci USA 105 45 (2008) 17481-17486